Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Clinical Pharmacology and Therapeutics(1)
European Journal of Clinical Pharmacology(1)
Journal of Psychopharmacology(1)
Pharmacopsychiatry(1)
Área de conocimiento
Farmacología(3)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(4)
ODS 10: Reducción de las desigualdades(3)
ODS 17: Alianzas para lograr los objetivos(3)
ODS 9: Industria, innovación e infraestructura(2)
Origen
scopus(4)
QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy
OtherAbstract:Palabras claves:debrisoquine, Haloperidol, QTcAutores:Adrián LLerena, Berecz R., De la Rubia A., Dorado P.Fuentes:scopusQTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients
ArticleAbstract: Thioridazine cardiotoxicity has been associated with a prolonged heart-rate corrected QT (QTc) interPalabras claves:CYP2D6, debrisoquine, QTc lengthening, ThioridazineAutores:Adrián LLerena, Berecz R., De la Rubia A., Dorado P.Fuentes:scopusRelationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
ArticleAbstract: The implication of cytochrome P450 CYP2D6 enzyme activity in the metabolism of the antipsychotic druPalabras claves:Autores:Adrián LLerena, Berecz R., De la Rubia A., Degrell I., Dorado P., Gómez J., Kellermann M.Fuentes:scopusPharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype
ArticleAbstract: Background and aim: Losartan is metabolized by polymorphic CYP2C9 to E-3174. Our aim was to evaluatePalabras claves:Autores:Adrián LLerena, Dahl M.L., Dorado P., Eliasson E., Forslund-Bergengren C., Sjoqvist F., Tybring G., Yasar U.Fuentes:scopus